中文名称: | Colivelin | ||||
---|---|---|---|---|---|
英文名称: | Colivelin | ||||
别名: | Colivelin Colivelin | ||||
CAS No: | 867021-83-8 | 分子式: | C119H206N32O35 | 分子量: | 2645.1 |
CAS No: | 867021-83-8 | ||||
分子式: | C119H206N32O35 | ||||
分子量: | 2645.1 |
基本信息
产品编号: |
C11136 |
||||
产品名称: |
Colivelin |
||||
CAS: |
867021-83-8 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量: |
2645.10 |
-20℃ |
1个月 |
||
化学名: |
|
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
|
|||
Ethanol |
|
||||
Water |
100mg/mL (37.8mM) |
||||
体内(现配现用): |
|
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
0.3781mL |
1.8903mL |
3.7806mL |
5mM |
0.0756mL |
0.3781mL |
0.7561mL |
10mM |
0.0378mL |
0.1890mL |
0.3781mL |
生物活性
产品描述 |
一种具有大脑通透性的神经保护肽(neuroprotectivepeptide),是STAT3的有效激活剂。Coliveli通过激活STAT3在体外抑制神经元死亡。Colivelin对神经毒性、Aβ沉积,神经元细胞凋亡,在神经退行性疾病显示出长期有利的影响。Colivelin具有潜力用于阿尔茨海默病和缺血性脑损伤的相关研究。 |
||
靶点 |
STAT3 |
Amyloid-β |
|
体外研究 |
Colivelin completely suppresses death induced by overexpressed FAD-causative genes and Aβ1-43 at a concentration of 100 fm,and keep its neuroprotective action at or above the levels of 1nm.Colivelin-induced neuroprotection occurs via two neuroprotective pathways:one mediated by Ca2+/calmodulin-dependent protein kinase IV,triggered by ADNF,and one mediated by signal transducer and activator of transcription 3,triggered by HN.Colivelin reverses caspase3,Bax and Bcl-2 expressions in HT22 cells medaited by rmMFG-E8 in the co-cultured cells under OGD condition.Colivelin (50µg/mL,4 hours) significantly increases the p-STAT3 protein levels in BV-2 cells. Western Blot Analysis |
||
Cell Line: |
BV-2 cells. |
||
Concentration: |
50µg/mL. |
||
Incubation Time: |
4 hours. |
||
Result: |
Increased p-STAT3 levels. |
||
Cell Viability Assay |
|||
Cell Line: |
KYSE70 and TE8 cells. |
||
Concentration: |
0.5μM. |
||
Incubation Time: |
1 hour (followed by CYT-Rx20 treatment) |
||
Result: |
Sgnificantly suppressed the viability in KYSE70 and TE8 cells. |
||
体内研究 |
Colivelin (intracerebroventricular administration;10 pmol/3μl;3 weeks) suppresses impairment in spatial working memory induced by repetitive intracerebroventricular injection of Aβ25-35 or Aβ1-42,in addition,it antagonizes neuronal loss in the CA1 region of hippocampus induced by hippocampal injection of Aβ1-42.Colivelin (intraperitoneal administration;1.4,7,or 35nM/0.21mL;on the Y-maze testday) suppresses memory impairment caused by 3-quinuclidinyl benzilateand restricts functional memory deficit.Colivelin (intraperitoneal injection;1mg/kg;14 days) results in improved motor and cognitive function with time by performance of mNSS,rotarod,and corner turning test.It also reduces lesion volume and improves neurological deficits after MCAO. |
||
Animal Model: |
CD-1 mice |
||
Dosage: |
10 pmol/3μl |
||
Administration: |
Intracerebroventricular administration |
||
Result: |
Completely suppressed Aβ 25-35-mediated impairment in spatial working memory and increased the number of immunoreactive neurons. |
||
|
|||
Animal Model: |
C57 mice |
||
Dosage: |
1.4,7,or 35nM/0.21mL |
||
Administration: |
Intraperitoneal administration |
||
Result: |
Protected against cholinotoxin-induced amnesia in mice. |
||
|
|||
Animal Model: |
Male C57BL/6 mice |
||
Dosage: |
1mg/kg |
||
Administration: |
Intraperitoneal administration |
||
Result: |
Protected against ischemic brain injury,and improves neurological outcomes |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )